Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Parkinson's Disease
60%
Parkinson
26%
Levodopa-induced Dyskinesia
23%
Idiopathic Parkinson's Disease
23%
Polygenic Risk Score
14%
Clinical Data
13%
Luxembourgish
13%
GBA1
12%
Dietary Model
11%
Disease Duration
11%
Disease Effects
11%
Dopaminergic Pathway
11%
Long-read Sequencing
11%
Cardiovascular History
11%
Prognostic Analysis
11%
Risk Variant
11%
Cross-cohort
11%
Authorship Criteria
11%
Metabolomics Data
11%
Outcome Prediction
11%
Gait Data
11%
Polygenic Background
11%
Mild Cognitive Impairment
11%
Cardiovascular Risk
11%
Xanthine Metabolism
11%
Preanalytical Variables
11%
Predictors of Cognitive Impairment
11%
Personalized Medicine
11%
Idiopathic PD
11%
Gut Microbiota
11%
Memory Impairment
11%
Variant Carriers
11%
Major Risk
11%
Open-source Tools
11%
Age of Onset
11%
Health Effects
11%
External Quality Assurance
11%
Translational Medicine
11%
Processing Methods
11%
Cross-sectional Observational Study
11%
Quality Assessment
11%
Multi-omics
11%
Clinical Phenotype
11%
Post-COVID
11%
Risk Factors
11%
Metabolic Dysfunction-associated Fatty Liver Disease (MAFLD)
11%
Machine Learning
11%
Aging Effect
11%
Fibrosis-4 Index
9%
DNA Extraction
9%
2-dimensional Shear Wave Elastography
8%
Metabolic Dysfunction-associated Steatohepatitis
7%
Preanalytical Factors
7%
Nucleic Acid Extraction
7%
RNA Extraction
7%
Differentially Methylated Positions
7%
95% Confidence Interval
6%
Parkinson Patients
6%
Non-carriers
5%
Family History
5%
Healthy Controls
5%
History of Cardiovascular Disease
5%
Public Health Information
5%
Parkinson's Disease-mild Cognitive Impairment
5%
Pathogenic Variants
5%
High Risk
5%
Gut Microbiota Composition
5%
Medicine and Dentistry
Parkinson's Disease
59%
Nonalcoholic Fatty Liver
35%
Meta-Analysis
35%
Fibrosis
29%
Gait
26%
Diagnostic Accuracy
25%
Metabolomics
23%
Biological Marker
19%
Diseases
17%
Education
14%
Systematic Review
13%
Histology
12%
Transient Elastography
12%
Infection
11%
Cord Blood
11%
Immunoglobulin
11%
Cohort Effect
11%
Hypoxic-Ischemic Encephalopathy
11%
COVID-19
11%
Observational Study
11%
Shear Wave Elastography
11%
Elastography
11%
Severe Acute Respiratory Syndrome Coronavirus 2
11%
Magnetic Resonance Imaging
11%
Patient-Data
11%
Tamsulosin
11%
Gut Microbiome
11%
Multi-Omics
11%
Mild Cognitive Impairment
11%
Translational Medicine
11%
Personalized Medicine
11%
Dopamine
11%
Levodopa-Induced Dyskinesia
11%
Cardiovascular System
11%
Public Health
10%
Comorbidity
9%
Area under the Curve
9%
Magnetic Resonance Elastography
8%
Cardiovascular Disease
6%
Liver Biopsy
6%
Stereotypic Movement Disorder
5%
Liver Cirrhosis
5%
Unified Parkinson's Disease Rating Scale
5%
Levodopa
5%
Neuroscience
Parkinson's Disease
100%
Mild Cognitive Impairment
26%
L-DOPA
23%
Dyskinesia
23%
Gut Microbiome
23%
Cardiovascular System
23%
Risk Factor
16%
Comorbidity
15%
Polygenic Risk Score
14%
Sleep Time
13%
Cognitive Disorders
13%
Electroencephalogram
11%
Hypothalamus
11%
MicroRNA
11%
Promoter Region
11%
Memory Disorder
11%
Progressive Supranuclear Palsy
11%
Glucocorticoid Receptor
11%
Methylation
11%
Gait
11%
Dopamine
11%
Genetics
10%
SARS Coronavirus
5%
Subjective Cognitive Decline
5%
Stereotypic Movement Disorder
5%